Join the 200th Anniversary Celebration

Original Article

Deaths Related to Liposuction

Rama B. Rao, M.D., Susan F. Ely, M.D., M.P.H.T.M., and Robert S. Hoffman, M.D.

N Engl J Med 1999; 340:1471-1475May 13, 1999

Abstract

Background

The technique of tumescent liposuction involves the subcutaneous infusion of a solution containing lidocaine, followed by the aspiration of fat through microcannulas. Although the recommended doses of lidocaine are as high as 55 mg per kilogram of body weight, few safety data are available. Since reporting of adverse events associated with tumescent liposuction is not mandatory, the incidence of complications and deaths is unknown.

Methods

We identified 5 deaths after tumescent liposuction among 48,527 deaths referred to the Office of Chief Medical Examiner of the City of New York between 1993 and 1998. The patients' records and postmortem examination results were reviewed to identify common contributory factors.

Results

The five patients had received lidocaine in doses ranging from 10 to 40 mg per kilogram. Other drugs, such as midazolam, were also administered. Three patients died as a result of precipitous intraoperative hypotension and bradycardia with no definitively identified cause. Postmortem blood lidocaine concentrations in two of the patients were 5.2 and 2 mg per liter. One patient died of fluid overload, and one died of deep venous thrombosis of calf veins with pulmonary thromboembolism after tumescent liposuction of the legs.

Conclusions

Tumescent liposuction can be fatal, perhaps in part because of lidocaine toxicity or lidocaine-related drug interactions.

Media in This Article

Table 1Deaths Related to Tumescent Liposuction.
Article

Liposuction is the most common cosmetic operation in the United States.1 The technique of tumescent liposuction is a relatively new procedure that has gained popularity in the past decade, in part because of its purported safety.2,3 Tumescent liposuction involves the subcutaneous infusion of a solution containing a local anesthetic drug, followed by the aspiration of fat through microcannulas.4 The infusate typically consists of 1 liter of normal saline containing 500 to 1000 mg of lidocaine, 0.25 to 1.0 mg of epinephrine, and 12.5 mmol of sodium bicarbonate.4,5 Its components provide prolonged local anesthesia and minimize blood loss. Large-volume liposuction, defined as the removal of more than 1500 ml of fat, may require the infusion of several liters of this solution.6 Depending on the extent of liposuction and the patient's preference, it can be performed with the patient under conscious sedation or epidural or general anesthesia.4,5,7 In contrast, older liposuction techniques were performed under general anesthesia, used larger cannulas and no infusate, and often necessitated blood transfusions.6,8

Despite doses of lidocaine as high as 55 mg per kilogram of body weight,9 few complications have been reported.10-14 Fatalities have been alluded to in medical correspondence but not described.15-18 We report here a series of five deaths related to tumescent liposuction.

Methods

We reviewed all autopsy reports from January 1, 1993, through December 31, 1996, and death-notification records from January 1, 1993, through March 1, 1998, at the Office of Chief Medical Examiner of the City of New York that had been identified by a computer search using the key words “liposuction,” “cosmetic,” “lipoplasty,” “plastic,” “lipectomy,” “abdominoplasty,” and “therapeutic complication.” We also queried city medical examiners about liposuction-related deaths currently under investigation. Five cases were identified. We then sought information about concomitant drug therapy, medical conditions other than obesity, and the details of the liposuction procedures from the patients' medical and autopsy records. The amount of lidocaine each patient received was calculated from the volume and concentration of lidocaine in the infusate, or the total number of milligrams of lidocaine infused, if available in the medical record. A total dose of lidocaine per kilogram was then calculated.

Results

During the period investigated, a total of 48,527 deaths were accepted under the jurisdiction of the Office of Chief Medical Examiner of the City of New York. Of these, 1001 deaths were certified as due to therapeutic complications, 5 of them related to liposuction. All five occurred during or after tumescent liposuction. Four of the procedures were performed by plastic surgeons and one by a general surgeon, and anesthesiologists were present during all of them. Family consent was obtained to describe four of these cases. The fifth death was caused by complications of hypotension and bradycardia; specific data regarding this case are omitted, however, owing to our inability to obtain consent. In one of the four cases described here, both the liposuction and the autopsy were performed in another jurisdiction and subsequently referred to the medical examiner's office in New York for review and consultation.

Each patient underwent a complete autopsy, including appropriate microscopical examination and collection of blood from the heart. Pertinent data regarding the four patients are summarized in Table 1Table 1Deaths Related to Tumescent Liposuction.. Resuscitation was attempted in all patients. Only the postmortem findings thought to be functionally important are described. None of the autopsies identified laryngeal edema consistent with anaphylaxis. Complete cardiac examination in each patient revealed a normal heart weight for body mass and no contributory cardiac cause of death. Postmortem toxicologic testing of blood, urine, and other available fluids and tissues did not identify illicit substances in any patient.

Patient 1

Patient 1 was a 33-year-old man with a remote history of appendectomy who underwent tumescent liposuction of the abdomen and flanks under general anesthesia with elective intubation as an outpatient. Preoperative serum potassium, creatinine, and aminotransferase concentrations were normal. Despite an arterial oxygen saturation of 100 percent, bradycardia and hypotension developed simultaneously 2.5 hours into the procedure; asystole ensued. Postmortem examination revealed 250 ml of peritoneal fluid without an identifiable cause, and no fluid overload, as determined by normal lung weights. Staining for fat emboli was negative. A blood sample collected 47 hours after death was positive for laudanosine, a metabolite of atracurium (0.3 mg per liter); meperidine (0.7 mg per liter); and lidocaine (5.2 mg per liter) (Table 1).

Patient 2

Patient 2 was a 40-year-old woman with asthma and normal liver function who underwent conscious sedation for tumescent liposuction of the flanks and back while prone as an outpatient. While speaking at a time when her arterial oxygen saturation was 96 to 97 percent, 2.3 hours into the procedure, she rotated to a supine position. Within 30 seconds, a wide-complex infranodal bradycardia developed; asystole ensued. Postmortem examination revealed no gross or microscopic abnormalities consistent with acute asthmatic bronchitis. Blood samples drawn 22.5 hours after death revealed midazolam and fentanyl, in concentrations too low to be quantified, and lidocaine (Table 1).

Patient 3

Patient 3 was a 33-year-old woman with an unspecified psychiatric disorder who was being treated with lithium, nortriptyline, buspirone, clonazepam, sertraline, trazodone, and carisoprodol. Her hemoglobin concentration was 12 g per deciliter. As an outpatient she received parenteral analgesia for bilateral augmentation mammoplasty and tumescent liposuction of the posterolateral thorax, arms, back, abdomen, thighs, buttocks, and knees, with an estimated blood loss of 700 ml. Because of postoperative pain she was hospitalized, at which time her hemoglobin concentration was 5.8 g per deciliter. She received 2 units of packed red cells, morphine sulfate through a patient-controlled analgesic pump, and 5 percent dextrose in Ringer's lactate (100 ml per hour, intravenously, throughout a hospitalization of two days). Furosemide was administered for hypoxia, wheezing, and peripheral edema.

Two hours after hospital discharge, she reported worsening dyspnea and had a syncopal event. She was found in ventricular fibrillation; resuscitation restored her circulation but she remained unresponsive. Her serum potassium and creatinine concentrations were normal. A chest radiograph revealed pulmonary edema, an echocardiogram was normal, and serum cardiac-enzyme concentrations were normal. She remained in an anoxic coma and was pronounced dead three days later. Postmortem examination revealed severe pulmonary edema with a combined lung weight of 1560 g. No pulmonary thromboemboli were identified. Toxicologic testing for lidocaine was not performed.

Patient 4

Patient 4 was a 54-year-old woman who underwent tumescent liposuction of the back, flanks, abdomen, and thighs under general anesthesia. Eighteen hours postoperatively, she arose from bed and became “lightheaded” and then unresponsive. Cardiac electrical activity was identified, but the patient's pulse was unobtainable. Postmortem examination revealed deep venous thrombosis of the left calf with saddle and distal pulmonary thromboemboli. Blood drawn 22.6 hours post mortem was positive for meperidine (0.8 mg per liter), normeperidine (0.1 mg per liter), and promethazine (0.1 mg per liter). The gastric contents (123 g) included the following amounts of drug: 0.3 mg of zolpidem and 0.4 mg of meperidine. Lidocaine values are shown in Table 1.

Discussion

The most striking aspect of this series is the incompletely explained deaths of Patients 1 and 2. Both had hypotension and bradycardia and then cardiac arrest. The differential diagnosis of hypotension and concomitant bradycardia includes primary myocardial dysfunction, disruption of the autonomic nervous system, end-stage systemic disorders (such as sepsis, hypoxia, and anaphylaxis), and toxic–metabolic causes. In these two cases, the first three categories can be ruled out by the case histories and pathological findings. Metabolic disturbances such as hypermagnesemia, hyperkalemia, and hypercalcemia are unlikely, because neither patient received any of these substances.

High doses of many drugs can cause hypotension and bradycardia. These include beta-adrenergic antagonists, the non-dihydropyridine calcium-channel blockers, cardiac glycosides, and centrally acting alpha-adrenergic agonists, to name a few. In rare instances, propofol causes hypotension and bradycardia during induction,19 but it is unlikely to account for the death of Patient 1, who tolerated the induction of anesthesia without incident.

Lidocaine can cause hypotension and bradycardia. It suppresses myocardial automaticity and causes some vasodilatation. When lidocaine is given to treat cardiac dysrhythmias, therapeutic plasma concentrations range from 2 to 5 mg per liter, and concentrations above 5 mg per liter are considered toxic.20 Typically, neurologic signs such as paresthesias, somnolence, and seizures are correlated with antemortem plasma concentrations of 5 to 9 mg per liter, and cardiovascular collapse has been described at concentrations above 10 mg per liter.20

In tumescent liposuction, reported doses of lidocaine range from 10 to 88 mg per kilogram,8 several times higher than the maximal recommended dose of 4.5 mg per kilogram (or up to 7 mg per kilogram with epinephrine) typically used for subcutaneous infiltration.21,22 The 1991 guidelines of the American Academy of Dermatologists for tumescent liposuction suggested a maximal dose of 35 mg of lidocaine per kilogram,23 which was increased to “at least 55 mg per kilogram” in 1997.24 This increase was based on studies demonstrating that most patients had plasma concentrations below the toxic range, despite being given these high doses.5,9,25,26

In tumescent liposuction, plasma lidocaine concentrations have been found to rise for 16 hours,6,9,25-27 or even 23 hours.28 The sampling intervals were often wide,6,9,27 and regression analyses were used to extrapolate maximal safe doses of 35 mg per kilogram27 and 55 mg per kilogram.9 These analyses failed to consider that hepatic metabolism of lidocaine by means of CYP3A4 is saturable.29 Once saturation occurs, absorption exceeds elimination, and plasma lidocaine concentrations increase precipitously. Administration of other drugs that are metabolized by or inhibit CYP3A4 can also alter lidocaine metabolism.29 Midazolam, in particular, may compete with lidocaine for enzymatic metabolism, protect against lidocaine-induced seizures, and alter mental status,29 delaying the diagnosis of lidocaine toxicity until the onset of cardiovascular collapse. General anesthesia or conscious sedation can also mask the early clinical signs of toxicity, as may have occurred in the cases of Patients 1 and 2. In some reports, “drowsiness” or “syncope,” which may represent neurotoxicity, was attributed to other causes.6,30

Interpreting the postmortem blood lidocaine concentrations in Patients 1 and 2 is difficult.31 No data regarding the stability of lidocaine in postmortem blood and tissue are available31,32; concentrations as low as 4 and 6 mg per liter have been reported in deaths attributed to the drug.32,33 In our series, the reported values may not reflect the concentrations in myocardial tissue at the time of cardiovascular collapse, owing to the redistribution half-life of the drug (8.5 minutes)20 and the effects of attempted resuscitation. Data on the active metabolite of lidocaine, monoethylglycinexylidide, are unavailable and may be relevant. Given the available clinicopathological information, we think lidocaine toxicity or lidocaine-related drug interactions are a possible explanation for the deaths of Patients 1 and 2.

The American Society of Plastic and Reconstructive Surgeons reports that the number of liposuction procedures performed by plastic surgeons increased by 200 percent from 1992 to 1997, with 149,042 procedures performed in 1997.2 The proportion involving the tumescent liposuction technique was not reported. The most recent survey from the American Academy of Cosmetic Surgery, representing several surgical disciplines, reported that 292,942 liposuction procedures were performed in 1996, an increase of more than 300 percent from 1990. Of these, 92 percent involved tumescent infusions, roughly half with general anesthesia.3

Deaths associated with earlier liposuction methods resulted primarily from pulmonary thromboembolism or fat emboli.34,35 A forerunner of tumescent liposuction, the “wet technique,” involved the subcutaneous infusion of a dilute solution of epinephrine.28 We found no reports of concomitant hypotension and bradycardia during or after liposuction with these methods.

During earlier liposuction procedures, the amount of intravenous hydration was based on the volume of fat aspirated. In tumescent liposuction, however, the infusate not only serves as a potential source of absorbable fluid, but also provides a tamponading effect, limiting fluid losses.5,6,30 Overhydration puts patients at risk for serious or fatal consequences,13 as occurred in Patient 3, whose severe hemodilution was erroneously attributed to blood loss alone.

Extensive tumescent liposuction of the abdomen and lower extremities can cause impedance of venous flow, release of local tissue factors, and postoperative immobilization. These can contribute to venous stasis and thrombogenesis, as occurred in Patient 4.

Anecdotes in the lay press suggest that these deaths after tumescent liposuction are not unique. According to press accounts, patients have died from “tumescent anesthesia,” epinephrine or lidocaine toxicity, hypothermia, and fluid overload.36-39 Editorials in the medical literature have mentioned deaths secondary to tumescent liposuction that were due to cardiac “depression,” pulmonary edema, and lidocaine toxicity,15-18 but these cases were not formally reported. There is no mandatory reporting or review of adverse events associated with this privately performed procedure, so the true incidence of complications and death is unknown.

Tumescent liposuction is not a trivial procedure, because it has the potential to kill otherwise healthy persons. Drug absorption and drug interactions, fluid management, prothrombogenic factors, and liposuction volume should be reevaluated for this popular cosmetic procedure. Deaths due to cosmetic surgery should be a matter for serious public concern.

Presented as a poster at the North American Congress of Clinical Toxicology, Orlando, Fla., September 14, 1998.

We are indebted to Charles S. Hirsch, M.D., and David R. Schomburg, R.P.A.-C., Office of Chief Medical Examiner of the City of New York, Mary Ann Howland, Pharm.D., of St. John's University, Jamaica, N.Y., and Lewis S. Nelson, M.D., of the New York City Poison Control Center, for their support in the preparation of the manuscript.

Source Information

From the New York City Poison Control Center, Department of Surgery–Emergency Medicine, New York University Medical Center and Bellevue Hospital Center (R.B.R., R.S.H.); and the Office of Chief Medical Examiner of the City of New York and the Department of Forensic Medicine, New York University Medical Center (S.F.E.) — all in New York.

Address reprint requests to Dr. Rao at the New York City Poison Control Center, 455 First Ave., Rm. 123, New York, NY 10016, or at .

References

References

  1. 1

    Dolsky RL. State of the art in liposuction. Dermatol Surg 1997;23:1192-1193
    CrossRef | Web of Science | Medline

  2. 2

    Number of liposuction procedures increase by 200 percent over five-year span. Arlington Heights, Ill.: Plastic Surgery Information Service, April 1998. (See http://www.plasticsurgery.org/mediactr/lipo-sta.htm.) (Also available from NAPS [document no. 05513 for three pages], c/o Microfiche Publications, 248 Hempstead Turnpike, West Hempstead, NY 11552.)

  3. 3

    1996 National cosmetic surgery statistics. Chicago: American Academy of Cosmetic Surgery, 1997:1-8.

  4. 4

    Klein JA. Tumescent technique chronicles: local anesthesia, liposuction, and beyond. Dermatol Surg 1995;21:449-457
    CrossRef | Web of Science | Medline

  5. 5

    Pitman GH, Aker JS, Tripp ZD. Tumescent liposuction: a surgeon's perspective. Clin Plast Surg 1996;23:633-641
    Web of Science | Medline

  6. 6

    Klein JA. Tumescent technique for local anesthesia improves safety in large-volume liposuction. Plast Reconstr Surg 1993;92:1085-1098
    CrossRef | Web of Science | Medline

  7. 7

    Knize DM, Fishell R. Use of preoperative subcutaneous “wetting solution“ and epidural block anesthesia for liposuction in the office-based surgical suite. Plast Reconstr Surg 1997;100:1867-1874
    CrossRef | Web of Science | Medline

  8. 8

    Lillis PJ. Liposuction surgery under local anesthesia: limited blood loss and minimal lidocaine absorption. J Dermatol Surg Oncol 1988;14:1145-1148
    Medline

  9. 9

    Ostad A, Kageyama N, Moy RL. Tumescent anesthesia with a lidocaine dose of 55 mg/kg is safe for liposuction. Dermatol Surg 1996;22:921-927
    CrossRef | Web of Science | Medline

  10. 10

    Bernstein G, Hanke CW. Safety of liposuction: a review of 9478 cases performed by dermatologists. J Dermatol Surg Oncol 1988;14:1112-1114
    Medline

  11. 11

    Hanke CW, Bernstein G, Bullock S. Safety of tumescent liposuction in 15,336 patients: national survey results. Dermatol Surg 1995;21:459-462
    CrossRef | Web of Science | Medline

  12. 12

    Hanke CW, Bullock S, Bernstein G. Current status of tumescent liposuction in the United States: national survey results. Dermatol Surg 1996;22:595-598
    CrossRef | Web of Science | Medline

  13. 13

    Gilliland MD, Coates N. Tumescent liposuction complicated by pulmonary edema. Plast Reconstr Surg 1997;99:215-219
    CrossRef | Web of Science | Medline

  14. 14

    Klein JA, Kassarjdian N. Lidocaine toxicity with tumescent liposuction: a case report of probable drug interactions. Dermatol Surg 1997;23:1169-1174
    CrossRef | Web of Science | Medline

  15. 15

    McShane RH. Whole blood loss in liposuction: a protocol for handling liposuction specimen. Plast Reconstr Surg 1997;100:281-281
    Web of Science | Medline

  16. 16

    Stone A. Tumescent technique with local anesthesia for liposuction. Plast Reconstr Surg 1995;95:603-605
    CrossRef | Web of Science | Medline

  17. 17

    Grazer FM, Meister FL. Complications of the tumescent formula for liposuction. Plast Reconstr Surg 1997;100:1893-1896
    CrossRef | Web of Science | Medline

  18. 18

    Klein JA. Titanic tumescent anesthesia. Dermatol Surg 1998;24:691-691
    Web of Science | Medline

  19. 19

    Bryson HM, Fulton BR, Faulds D. Propofol: an update of its use in anaesthesia and conscious sedation. Drugs 1995;50:513-559
    CrossRef | Web of Science | Medline

  20. 20

    Goldfrank LR, Flomenbaum NE, Lewin NA, Weisman RS, Howland MA, Hoffman RS, eds. Goldfrank's toxicologic emergencies. 5th ed. Norwalk, Conn.: Appleton & Lange, 1994:717-9.

  21. 21

    Catterall WA, Mackie K. Local anesthetics. In: Hardman JG, Limbird LE, eds. Goodman & Gilman's the pharmacological basis of therapeutics. 9th ed. New York: McGraw-Hill, 1996:331-47.

  22. 22

    Physicians' desk reference. 52nd ed. Montvale, N.J.: Medical Economics, 1998:582-5.

  23. 23

    Drake LA, Ceilley RI, Cornelison RL, et al. Guidelines of care for liposuction. J Am Acad Dermatol 1991;24:489-494
    CrossRef | Web of Science | Medline

  24. 24

    Guiding principles for liposuction: the American Society for Dermatologic Surgery, February 1997. Dermatol Surg 1997;23:1127-1129
    Web of Science | Medline

  25. 25

    Samdal F, Amland PF, Bugge JF. Plasma lidocaine levels during suction-assisted lipectomy using large doses of dilute lidocaine with epinephrine. Plast Reconstr Surg 1994;93:1217-1223
    CrossRef | Web of Science | Medline

  26. 26

    Klein JA. The tumescent technique: anesthesia and modified liposuction technique. Dermatol Clin 1990;8:425-437
    Web of Science | Medline

  27. 27

    Klein JA. Tumescent technique for regional anesthesia permits lidocaine doses of 35 mg/kg for liposuction. J Dermatol Surg Oncol 1990;16:248-263
    Medline

  28. 28

    Burk RW III, Guzman-Stein G, Vasconez LO. Lidocaine and epinephrine levels in tumescent technique liposuction. Plast Reconstr Surg 1996;97:1379-1384
    CrossRef | Web of Science | Medline

  29. 29

    Parkinson A. Biotransformation of xenobiotics. In: Klaassen CD, ed. Casarett and Doull's toxicology: the basic science of poisons. 5th ed. New York: McGraw-Hill, 1996:113-86.

  30. 30

    Pitman GH. Liposuction & anesthetic surgery. St. Louis: Quality Medical Publishing, 1993:67-9, 249, 335, 375, 389.

  31. 31

    Prouty RW, Anderson WH. The forensic science implications of site and temporal influences on postmortem blood-drug concentrations. J Forensic Sci 1990;35:243-270
    Web of Science | Medline

  32. 32

    Peat MA, Deyman ME, Crouch DJ, Margot P, Finkle BS. Concentrations of lidocaine and monoethylglycylxylidide (MEGX) in lidocaine associated deaths. J Forensic Sci 1985;30:1048-1057
    Web of Science | Medline

  33. 33

    Christie JL. Fatal consequences of local anesthesia: report of five cases and a review of the literature. J Forensic Sci 1976;21:671-679
    Medline

  34. 34

    Teimourian B, Rogers WB. A national survey of complications associated with suction lipectomy: a comparative study. Plast Reconstr Surg 1989;84:628-631
    CrossRef | Web of Science | Medline

  35. 35

    Christman KD. Death following suction lipectomy and abdominoplasty. Plast Reconstr Surg 1986;78:428-428
    CrossRef | Web of Science | Medline

  36. 36

    Lasswell M. As she lay dying. Allure. August 1997:128-33, 151.

  37. 37

    Allen JE. The ugly side of liposuction surfaces: California probes deaths of 3 from surgery. Star-Ledger. August 26, 1997:20.

  38. 38

    Doctors' licenses taken after liposuction death. New York Times. November 29, 1997:10.

  39. 39

    Chase M. Extreme liposuction is exposing patients to unnecessary risk. Wall Street Journal. January 18, 1999:B1.

Citing Articles (88)

Citing Articles

  1. 1

    Sarah Ciechanowicz, Vinod Patil. (2012) Lipid Emulsion for Local Anesthetic Systemic Toxicity. Anesthesiology Research and Practice 2012, 1-11
    CrossRef

  2. 2

    Kirsty Stewart. (2011) Drug-induced bradycardia. Adverse Drug Reaction Bulletin &NA;:269, 1035-1038
    CrossRef

  3. 3

    Fedor Lurie. (2011) COMMENTARY: Endovenous Mechanochemical Ablation: How Much Improvement Is Good Enough?. Journal of Endovascular Therapy 18:3, 335-337
    CrossRef

  4. 4

    Roland Boeni. (2011) Safety of Tumescent Liposuction under Local Anesthesia in a Series of 4,380 Patients. Dermatology 222:3, 278-281
    CrossRef

  5. 5

    Richard Berkowitz, David Barinholtz. 2011. Anesthesia for Office-Based Pediatric Anesthesia. , 1077-1095.
    CrossRef

  6. 6

    MD Schmittner, J Faulhaber, B Kemler, W Koenen, JO Thumfart, C Weiss, M Neumaier, GC Beck. (2010) Influence of high dose tumescent local anaesthesia with prilocaine on systemic interleukin (IL)-6, IL-8 and tumour necrosis factor-α. Journal of the European Academy of Dermatology and Venereology 24:12, 1400-1405
    CrossRef

  7. 7

    J.W. Kuhbier, B. Weyand, H. Sorg, C. Radtke, P.M. Vogt, K. Reimers. (2010) Stammzellen aus dem Fettgewebe. Der Chirurg 81:9, 826-832
    CrossRef

  8. 8

    Louis Habbema. (2010) Efficacy of tumescent local anesthesia with variable lidocaine concentration in 3430 consecutive cases of liposuction. Journal of the American Academy of Dermatology 62:6, 988-994
    CrossRef

  9. 9

    Matthew C. Camp, Wendy W. Wong, Ryan Y. Wong, Jennifer S. Camp, Andrew K. Son, Subhas C. Gupta. (2010) Who Is Providing Aesthetic Surgery? A Detailed Examination of the Geographic Distribution and Training Backgrounds of Cosmetic Practitioners in Southern California. Plastic and Reconstructive Surgery 125:4, 1257-1262
    CrossRef

  10. 10

    Taj M. Kattapuram, Laura L. Avery. (2010) Ureteral tear at the ureteropelvic junction: a complication of liposuction. Emergency Radiology 17:1, 79-82
    CrossRef

  11. 11

    João Cantarelli, Moacir F. Godoy. (2009) Safe Limits for Aspirate Volume Under Wet Liposuction. Obesity Surgery 19:12, 1642-1645
    CrossRef

  12. 12

    Phillip C. Haeck, Jennifer A. Swanson, Karol A. Gutowski, C Bob Basu, Amy G. Wandel, Lynn A. Damitz, Neal R. Reisman, Stephen B. Baker. (2009) Evidence-Based Patient Safety Advisory: Liposuction. Plastic and Reconstructive Surgery 124, 28S-44S
    CrossRef

  13. 13

    Dilek Şenen, D. Atakul, G. Erten, B. Erdoğan, N. Lortlar. (2009) Evaluation of the Risk of Systemic Fat Mobilization and Fat Embolus Following Liposuction with Dry and Tumescent Technique: An Experimental Study on Rats. Aesthetic Plastic Surgery 33:5, 730-737
    CrossRef

  14. 14

    Dirk M. Elston, James S. Taylor, Brett Coldiron, Antoinette F. Hood, Sandra I. Read, Jack S. Resneck, Robert S. Kirsner, John C. Maize, Sabra Sullivan, John Laskas, C. William Hanke. (2009) Patient safety. Journal of the American Academy of Dermatology 61:2, 179-190
    CrossRef

  15. 15

    Krystyna Miszkiewicz, Isabelle Perreault, Genevieve Landes, Patrick G. Harris, John S. Sampalis, Alexandre Dionyssopoulos, Andreas Nikolis. (2009) Venous thromboembolism in plastic surgery: incidence, current practice and recommendations. Journal of Plastic, Reconstructive & Aesthetic Surgery 62:5, 580-588
    CrossRef

  16. 16

    M Nourshahi, S Ahmadizad, H Nikbakht, M A Heidarnia, E Ernst. (2009) The effects of triple therapy (acupuncture, diet and exercise) on body weight: a randomized, clinical trial. International Journal of Obesity 33:5, 583-587
    CrossRef

  17. 17

    Niloufar Roustaei, Seyed Jafar Masoumi Lari, Majid Chalian, Hamid Chalian, Hooman Bakhshandeh. (2009) Safety of Ultrasound-Assisted Liposuction: A Survey of 660 Operations. Aesthetic Plastic Surgery 33:2, 213-218
    CrossRef

  18. 18

    Pamela A. Morganroth, Joel M. Gelfand, Anokhi Jambusaria, David J. Margolis, Christopher J. Miller. (2009) A randomized, double-blind comparison of the total dose of 1.0% lidocaine with 1:100,000 epinephrine versus 0.5% lidocaine with 1:200,000 epinephrine required for effective local anesthesia during Mohs micrographic surgery for skin cancers. Journal of the American Academy of Dermatology 60:3, 444-452
    CrossRef

  19. 19

    Joseph P. Hunstad, Remus Repta. 2009. Liposuction in Abdominal Contouring. , 15-24.
    CrossRef

  20. 20

    Russell K. McAllister, Tricia A. Meyer, Timothy M. Bittenbinder. (2008) Can Local Anesthetic–Related Deaths during Liposuction Be Prevented?. Plastic and Reconstructive Surgery 122:6, 232e-233e
    CrossRef

  21. 21

    Umar H. Choudry, Petr Hyza, Jason Lane, Paul Petty. (2008) The Importance of Preoperative Hemoglobin Evaluation in Large Volume Liposuction. Annals of Plastic Surgery 61:3, 230-234
    CrossRef

  22. 22

    J Bauer Horton, Jeffrey E. Janis, Rod J. Rohrich. (2008) MOC-PS(SM) CME Article: Patient Safety in the Office-Based Setting. Plastic and Reconstructive Surgery 122:Supplement, 1-21
    CrossRef

  23. 23

    Marcus Lehnhardt, Heinz H. Homann, Adrien Daigeler, Joerg Hauser, Patricia Palka, Hans U. Steinau. (2008) Major and Lethal Complications of Liposuction: A Review of 72 Cases in Germany between 1998 and 2002. Plastic and Reconstructive Surgery 121:6, 396e-403e
    CrossRef

  24. 24

    María A. Martínez, Salomé Ballesteros, Luis J. Segura, Manuel García. (2008) Reporting a fatality during tumescent liposuction. Forensic Science International 178:1, e11-e16
    CrossRef

  25. 25

    Eric C. Liao, Amir H. Taghinia, Lisa P. Nguyen, Janet H. Yueh, James W. May, Dennis P. Orgill. (2008) Incidence of Hematoma Complication with Heparin Venous Thrombosis Prophylaxis after TRAM Flap Breast Reconstruction. Plastic and Reconstructive Surgery 121:4, 1101-1107
    CrossRef

  26. 26

    William B. Henghold, Brent R. Moody. 2008. Tumescent Anesthesia. , 107-132.
    CrossRef

  27. 27

    Mahesh Mallappa, Mohan Rangaswamy, Mohamed Faruq Badiuddin. (2007) Small Intestinal Perforation and Peritonitis After Liposuction. Aesthetic Plastic Surgery 31:5, 589-592
    CrossRef

  28. 28

    Yitzchak Ramon, Yoreh Barak, Yehuda Ullmann, Erica Hoffer, Danielle Yarhi, Yedidia Bentur. (2007) Pharmacokinetics of High-Dose Diluted Lidocaine in Local Anesthesia for Facelift Procedures. Therapeutic Drug Monitoring 29:5, 644-647
    CrossRef

  29. 29

    K. Rudlof, H. Rüffert, M. Wehner, T. Wetzig, K. Eichhorn, D. Olthoff. (2007) Tumeszenzlokalanästhesie bei dermatologischen Eingriffen. Der Anaesthesist 56:8, 785-789
    CrossRef

  30. 30

    CW Hanke, G Sattler, AL Leonard. 2007. Safety of liposuction surgery. , 161-167.
    CrossRef

  31. 31

    Kelley Pagliai Redbord, C William Hanke. (2007) Safety of liposuction using tumescent local anesthesia. Expert Review of Dermatology 2:2, 121-124
    CrossRef

  32. 32

    Antonio R. Basile, Flavio Fernandes, Vinicius Volpe Basile, Filipe V. Basile. (2006) Fluid Resuscitation in Liposuction: A Prospective Analysis of Infiltrate-to-Total Aspirate Ratios Lower Than Used for the Superwet Technique. Aesthetic Plastic Surgery 30:6, 659-665
    CrossRef

  33. 33

    Devesh Sharma, Gregory Dalencourt, Thomas Bitterly, Peter N. Benotti. (2006) Small Intestinal Perforation and Necrotizing Fasciitis After Abdominal Liposuction. Aesthetic Plastic Surgery 30:6, 712-716
    CrossRef

  34. 34

    W COLEMANIV, S HENDRYII. (2006) Principles of Liposuction. Seminars in Cutaneous Medicine and Surgery 25:3, 138-144
    CrossRef

  35. 35

    J Bauer Horton, Edward M. Reece, George Broughton, Jeffrey E. Janis, James F. Thornton, Rod J. Rohrich. (2006) Patient Safety in the Office-Based Setting. Plastic and Reconstructive Surgery 117:4, 61e-80e
    CrossRef

  36. 36

    M??rio Luiz Ribeiro Monteiro, Frederico Castelo Moura, Leonardo Provetti Cunha. (2006) Bilateral Visual Loss Complicating Liposuction in a Patient with Idiopathic Intracranial Hypertension. Journal of Neuro-Ophthalmology 26:1, 34-37
    CrossRef

  37. 37

    Germán Newall, Amado Ruiz-Razura, Henry A. Mentz, Christopher K. Patronella, Francis R. Ibarra, Alberto Zarak. (2006) A Retrospective Study on the Use of a Low-Molecular-Weight Heparin for Thromboembolism Prophylaxis in Large-Volume Liposuction and Body Contouring Procedures. Aesthetic Plastic Surgery 30:1, 86-95
    CrossRef

  38. 38

    2006. Lidocaine. , 2051-2060.
    CrossRef

  39. 39

    2006. Local anesthetics. , 2116-2157.
    CrossRef

  40. 40

    Richard Berkowitz. 2006. Office-Based Pediatric Anesthesia. , 856-873.
    CrossRef

  41. 41

    H. Nordström, K. Stånge. (2005) Plasma lidocaine levels and risks after liposuction with tumescent anaesthesia. Acta Anaesthesiologica Scandinavica 49:10, 1487-1490
    CrossRef

  42. 42

    Brett Coldiron, Ann Harriott Fisher, Eric Adelman, Christopher B. Yelverton, Rajesh Balkrishnan, Marc A. Feldman, Steven R. Feldman. (2005) Adverse Event Reporting: Lessons Learned from 4 Years of Florida Office Data. Dermatologic Surgery 31:9, 1079-1093
    CrossRef

  43. 43

    Robert A. Yoho, Jeremy J. Romaine, Deborah O'Neil. (2005) Review of the Liposuction, Abdominoplasty, and Face-Lift Mortality and Morbidity Risk Literature. Dermatologic Surgery 31:7, 733-743
    CrossRef

  44. 44

    Daniel Most, Jeffrey Kozlow, Jennifer Heller, Michele A. Shermak. (2005) Thromboembolism in Plastic Surgery. Plastic and Reconstructive Surgery 115:2, 20e-30e
    CrossRef

  45. 45

    Peter Van Nguyen, Justin Merszei, Rupal Patel, Luan D. Truong, Venkataraman Ramanathan. (2005) Acute Renal Failure After Liposuction. Renal Failure 27:6, 787-790
    CrossRef

  46. 46

    N. Lindenblatt, L. Belusa, B. Tiefenbach, W. Schareck, R.R. Olbrisch. (2004) Prilocaine Plasma Levels and Methemoglobinemia in Patients Undergoing Tumescent Liposuction Involving Less Than 2,000 ml. Aesthetic Plastic Surgery 28:6, 435-440
    CrossRef

  47. 47

    John G. Hancox, Arun P. Venkat, Alicia Hill, Gloria F. Graham, Phillip M. Williford, Brett Coldiron, Steven R. Feldman, Rajesh Balkrishnan. (2004) Why Are There Differences in the Perceived Safety of Office-Based Surgery?. Dermatologic Surgery 30:11, 1377-1379
    CrossRef

  48. 48

    Y. Kenan Coban, Fatma Inanc. (2004) Low-Volume Tumescent Liposuction Does Not Change Plasma Malondialdehyde Levels: A Preliminary Study. Aesthetic Plastic Surgery 28:5, 321-323
    CrossRef

  49. 49

    Charlotte Bell. (2004) Tumescent Local Anesthesia for the Surgical Treatment of Burns and Postburn Sequelae in Pediatric Patients. Survey of Anesthesiology 48:5, 243-244
    CrossRef

  50. 50

    Rod Foroozan, Joseph Varon. (2004) Bilateral Anterior Ischemic Optic Neuropathy After Liposuction. Journal of Neuro-Ophthalmology 24:3, 211-213
    CrossRef

  51. 51

    Spencer A. Brown, Avron H. Lipschitz, Jeffrey M. Kenkel, Evan Sorokin, Greene Shepherd, Stefan Grebe, Lawrence K. Oliver, Maureen Luby, Rod J. Rohrich. (2004) Pharmacokinetics and Safety of Epinephrine Use in Liposuction. Plastic and Reconstructive Surgery 114:3, 756-763
    CrossRef

  52. 52

    Avron H. Lipschitz, Jeffrey M. Kenkel, Maureen Luby, Evan Sorokin, Rod J. Rohrich, Spencer A. Brown. (2004) Electrolyte and Plasma Enzyme Analyses during Large-Volume Liposuction. Plastic and Reconstructive Surgery 114:3, 766-775
    CrossRef

  53. 53

    Jeffrey M. Kenkel, Avron H. Lipschitz, Greene Shepherd, Victor W. Armstrong, Frank Streit, Michael Oellerich, Maureen Luby, Rod J. Rohrich, Spencer A. Brown. (2004) Pharmacokinetics and Safety of Lidocaine and Monoethylglycinexylidide in Liposuction: A Microdialysis Study. Plastic and Reconstructive Surgery 114:2, 516-524
    CrossRef

  54. 54

    Jeffrey M. Kenkel, Avron H. Lipschitz, Maureen Luby, Ian Kallmeyer, Evan Sorokin, Eric Appelt, Rod J. Rohrich, Spencer A. Brown. (2004) Hemodynamic Physiology and Thermoregulation in Liposuction. Plastic and Reconstructive Surgery 114:2, 503-513
    CrossRef

  55. 55

    William Hanke, Sue Ellen Cox, Naomi Kuznets, William P. Coleman. (2004) Tumescent Liposuction Report Performance Measurement Initiative: National Survey Results. Dermatologic Surgery 30:7, 967-978
    CrossRef

  56. 56

    Zafer Salim Tabboush. (2004) Tumescent Anesthesia: A Concern of Anesthesiologists. Anesthesia & Analgesia1190
    CrossRef

  57. 57

    Jeffrey M. Kenkel, Spencer A. Brown, Edward J. Love, Jean P. Waddle, Jo Ellen Krueger, Debby Noble, Jack B. Robinson, Rod J. Rohrich. (2004) Hemodynamics, Electrolytes, and Organ Histology of Larger-Volume Liposuction in a Porcine Model. Plastic and Reconstructive Surgery 113:5, 1391-1399
    CrossRef

  58. 58

    Ronald E. Iverson, Dennis J. Lynch. (2004) Practice Advisory on Liposuction. Plastic and Reconstructive Surgery 113:5, 1478-1490
    CrossRef

  59. 59

    Amir Cohen, Kamal Kishore, Leo Wolansky, Larry Frohman. (2004) Pituitary Apoplexy Occurring During Large Volume Liposuction Surgery. Journal of Neuro-Ophthalmology 24:1, 31-33
    CrossRef

  60. 60

    Martin G Hubmer, Horst Koch, Franz M Haas, Michael Horn, Oliver Sankin, Erwin Scharnagl. (2004) Necrotizing fasciitis after ambulatory phlebectomy performed with use of tumescent anesthesia. Journal of Vascular Surgery 39:1, 263-265
    CrossRef

  61. 61

    Leonardo Bussolin, Paolo Busoni, Letizia Giorgi, Massimo Crescioli, Andrea Messeri. (2003) Tumescent Local Anesthesia for the Surgical Treatment of Burns and Postburn Sequelae in Pediatric Patients. Anesthesiology 99:6, 1371-1375
    CrossRef

  62. 62

    Timothy Corcoran Flynn, Brett Coldiron, Rhoda S. Narins. (2003) Liposuction Using Dilute Local Anesthesia. Dermatologic Surgery 29:11, 1144-1145
    CrossRef

  63. 63

    Rajesh Balkrishnan, Inderjit K. Gill, Jeffrey A. Vallee, Steven R. Feldman. (2003) No Smoking Gun: Findings From a National Survey of Office-Based Cosmetic Surgery Adverse Event Reporting. Dermatologic Surgery 29:11, 1093-1099
    CrossRef

  64. 64

    Lázaro Cárdenas-Camarena. (2003) Lipoaspiration and Its Complications: A Safe Operation. Plastic and Reconstructive Surgery 112:5, 1435-1441
    CrossRef

  65. 65

    Paul F. White. (2003) Anesthesia Outside the Operating Room: International Anesthesia Clinics, Volume 41, No. 2. Anesthesia & Analgesia930-931
    CrossRef

  66. 66

    Hidenobu Oba. (2003) LARGE-VOLUME TUMESCENT ANESTHESIA FOR EXTENSIVE LIPOSUCTION IN ORIENTAL PATIENTS: LIDOCAINE TOXICITY AND ITS SAFE DOSE LEVEL. Plastic and Reconstructive Surgery 111:2, 945-946
    CrossRef

  67. 67

    Rajesh Balkrishnan, Alicia Hill, Steven R Feldman, Gloria F Graham. (2003) Efficacy, Safety, and Cost of Office-Based Surgery: A Multidisciplinary Perspective. Dermatologic Surgery 29:1, 1-6
    CrossRef

  68. 68

    Leanne Groban. (2003) Central Nervous System and Cardiac Effects From Long-Acting Amide Local Anesthetic Toxicity in the Intact Animal Model. Regional Anesthesia and Pain Medicine 28:1, 3-11
    CrossRef

  69. 69

    G FULDA, S KHAN, D ZABEL. (2003) Special issues in plastic and reconstructive surgery. Critical Care Clinics 19:1, 91-108
    CrossRef

  70. 70

    Tamara Salam Housman, Naomi Lawrence, Beverly G. Mellen, Mary Noel George, James San Filippo, K. Andrew Cerveny, Mario DeMarco, Steven R. Feldman, Alan B. Fleischer. (2002) The Safety of Liposuction: Results of a National Survey. Dermatologic Surgery 28:11, 971-978
    CrossRef

  71. 71

    Terese T. Horlocker, Denise J. Wedel. (2002) Local anesthetic toxicity—does product labeling reflect actual risk?. Regional Anesthesia and Pain Medicine 27:6, 562-567
    CrossRef

  72. 72

    Michael F. Mulroy. (2002) Systemic toxicity and cardiotoxicity from local anesthetics. Regional Anesthesia and Pain Medicine 27:6, 556-561
    CrossRef

  73. 73

    J BRAMHALL. (2002) Regional anesthesia for aesthetic surgery. Seminars in Cutaneous Medicine and Surgery 21:1, 3-26
    CrossRef

  74. 74

    Marc Laffon, Christian Jayr, Pascal Barbry, Ybing Wang, Hans G. Folkesson, Jean-Francois Pittet, Christine Clerici, Michael A. Matthay. (2002) Lidocaine Induces a Reversible Decrease in Alveolar Epithelial Fluid Clearance in Rats. Anesthesiology 96:2, 392-399
    CrossRef

  75. 75

    Rodney Cooter, Wendy Babidge, Keith Mutimer, Peter Wickham, David Robinson, George Kiroff, Andrew Chapman, Guy Maddern. (2001) Ultrasound-assisted lipoplasty. ANZ Journal of Surgery 71:5, 309-317
    CrossRef

  76. 76

    Rudolph H. de Jong, Frederick M. Grazer. (2001) Perioperative Management of Cosmetic Liposuction. Plastic and Reconstructive Surgery 107:4, 1039-1044
    CrossRef

  77. 77

    Jack G. Bruner, Rudolph H. de Jong. (2001) Lipoplasty Claims Experience of U.S. Insurance Companies. Plastic and Reconstructive Surgery 107:5, 1285-1291
    CrossRef

  78. 78

    Robert A. Yoho. (2001) Lidocaine Toxicity. International Journal of Cosmetic Surgery and Aesthetic Dermatology 3:1, 1-2
    CrossRef

  79. 79

    A. C. Markey. (2001) Liposuction in cosmetic dermatology. Clinical and Experimental Dermatology 26:1, 3-5
    CrossRef

  80. 80

    Alireza Minagar, Norman J Schatz, Joel S Glaser. (2000) Liposuction and ischemic optic neuropathy. Journal of the Neurological Sciences 181:1-2, 132-136
    CrossRef

  81. 81

    Donat R. Spahn. (2000) Anaesthesia outside the operating room. Current Opinion in Anaesthesiology 13:4, 407
    CrossRef

  82. 82

    Mia Talmor, Thomas J. Fahey, Jeffrey Wise, Lloyd A. Hoffman, Philip S. Barie. (2000) Large-Volume Liposuction Complicated by Retroperitoneal Hemorrhage: Management Principles and Implications for the Quality Improvement Process. Plastic & Reconstructive Surgery 105:6, 2244
    CrossRef

  83. 83

    Bahman Teimourian, Medhi N. Adham. (2000) A National Survey of Complications Associated with Suction Lipectomy: What We Did Then and What We Do Now. Plastic and Reconstructive Surgery 105:5, 1881-1884
    CrossRef

  84. 84

    Frederick M. Grazer, Rudolph H. de Jong. (2000) Fatal Outcomes from Liposuction: Census Survey of Cosmetic Surgeons. Plastic & Reconstructive Surgery 105:1, 436-446
    CrossRef

  85. 85

    Jeffrey A. Klein. (1999) Lidocaine Is Not Necessary in Liposuction. Plastic & Reconstructive Surgery 104:6, 1903-1906
    CrossRef

  86. 86

    Helmut Breuninger, Pierre Sebastian Hobbach, Franz Schimek. (1999) Ropivacaine: An Important Anesthetic Agent for Slow Infusion and Other Forms of Tumescent Anesthesia. Dermatologic Surgery 25:10, 799-802
    CrossRef

  87. 87

    (1999) Deaths Related to Liposuction. New England Journal of Medicine 341:13, 1000-1003
    Full Text

  88. 88

    &NA;. (1999) Death in liposuction patients related to lidocaine?. Reactions Weekly &NA;:752, 3
    CrossRef

Letters